Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 8Breast Neoplasms 7Uterine Cervical Neoplasms 6Uterine Cervical Dysplasia 5Persistent Infection 4Melanoma 4Glioblastoma 3Carcinoma, Non-Small-Cell Lung 3Sarcoma 2Neuroblastoma 2Lung Neoplasms 2Influenza, Human 2HIV Infections 2Glioma 2Condylomata Acuminata 2Breast Neoplasms, Male 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Spondylitis, Ankylosing 1Small Cell Lung Carcinoma 1Rheumatic Diseases 1Recurrence 1Psoriasis 1Prostatic Neoplasms 1Papillomavirus Infections 1Pancreatic Neoplasms 1Neuroectodermal Tumors, Primitive 1Neoplasms, Nerve Tissue 1

Interventions

Adalimumab 4Etanercept 3secukinumab 1golimumab 1Vaccines 1Tumor Necrosis Factors 1Tai Ji 1Sulfasalazine 1Standard of Care 1Saline Solution 1Practice Guidelines as Topic 1Methods 1Meloxicam 1Interviews as Topic 1Infliximab 1Herpes Zoster Vaccine 1Exercise 1Etoricoxib 1Educational Status 1Early Intervention, Educational 1Celecoxib 1Anti-Inflammatory Agents, Non-Steroidal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Spondylitis, Ankylosing × Vaccines × Clear all
NCT02538341 2021-11-23

Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)

University of Alabama at Birmingham

Phase 2 Completed
617 enrolled 17 charts

Arthritis, Arthritis, Rheumatoid, Crohn Disease, Psoriasis, Spondylitis, Ankylosing, Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡